Erlotinib Completed Phase 2 Trials for Metastatic Adenocarcinoma of the Esophagus / Metastatic Adenocarcinoma of Gastric Cardia / Unresectable Adenocarcinoma of the Esophagus / Unresectable Adenocarcinoma of Gastric Cardia Treatment